Fresenius' final leg M&A financing from equity-neutral convertible

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Fresenius' final leg M&A financing from equity-neutral convertible

medical right size

Fresenius, the German healthcare business, has turned to the equity-linked bond market to source its final piece of funding for the acquisition of 43 hospitals from Rhön-Klinikum last year.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article